1-4 of 4
Danielle S. Wallace
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

How I Treat Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Danielle S. Wallace, Kah Poh Loh, Carla Casulo
Journal: Blood
Blood blood.2024024788.
https://doi.org/10.1182/blood.2024024788
Published: 2024
Journal Articles

Ready, AIM, stop: ibrutinib plus venetoclax in MCL

Clinical Trials & Observations
Danielle S. Wallace, Paul M. Barr
Journal: Blood
Blood (2024) 144 (8): 800–802.
https://doi.org/10.1182/blood.2024025021
Published: 2024
Journal Articles

Rituximab Induces an Inflammatory Cytokine Response with Increased IP-10 (CXCR10) in Patients with Infusion Reactions

Clive S. Zent, Jeremiah E. Moore, Paige C. Bloom, Charles C. Chu, Jennifer E. Bruno, Christine A. Herne, Andrea M Baran, Sally A. Quataert, Tim R. Mosmann, Ronald P. Taylor, Danielle S. Wallace, Michael R. Elliott, Paul M. Barr
Journal: Blood
Blood (2022) 140 (Supplement 1): 4171–4172.
https://doi.org/10.1182/blood-2022-162858
Published: 2022
Journal Articles

Phase II Study of Acalabrutinib and High-Frequency Low-Dose Subcutaneous Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Danielle S. Wallace, Andrea M. Baran, Jonathan W. Friedberg, Patrick M. Reagan, Carla Casulo, Mijamin Friend, Alyssa R. Williams, Peter D Dakin, Clive S. Zent, Paul M. Barr
Journal: Blood
Blood (2021) 138 (Supplement 1): 2640.
https://doi.org/10.1182/blood-2021-145490
Published: 2021